amlodipine has been researched along with cardiovascular agents in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (17.24) | 18.2507 |
| 2000's | 13 (44.83) | 29.6817 |
| 2010's | 7 (24.14) | 24.3611 |
| 2020's | 4 (13.79) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, V; Garg, P; Sagar, S; Singhal, PC | 1 |
| Bretnall, AE; Clarke, GS | 1 |
| Meyer, C | 1 |
| Adachi, T; Naito, Y; Narita, H; Ohara, N; Yokota, S; Yoshida, H | 1 |
| Chierchia, SL; Fragasso, G; Margonato, A; Rossetti, E; Xuereb, M; Xuereb, RG | 1 |
| Ahn, YK; Bae, Y; Cho, JG; Cho, JH; Jeong, MH; Kang, JC; Kang, KT; Kim, KH; Kim, NH; Kim, SH; Lee, SH; Park, JC; Rhew, JY | 1 |
| Chugh, SK; Digpal, K; Hutchinson, T; Lahiri, A; McDonald, CJ; Miller, AJ | 1 |
| Beckerman, B; Brennan, C; Bultas, J; Deanfield, JE; Detry, JM; Lichtlen, PR; Sellier, P; Thaulow, E; Young, ST | 1 |
| Devaki, T; Ebenezar, KK; Sathish, V | 1 |
| Chaitman, BR; Chumakova, G; Kuch, J; Parker, JO; Pepine, CJ; Skettino, SL; Skopal, J; Wang, W; Wolff, AA | 1 |
| Chakrabarty, AN; Dastidar, SG; Dutta, NK; Ganguly, K; Kumar, KA; Mazumdar, K | 1 |
| Asok Kumar, K; Dastidar, SG; Dutta, NK; Karak, P; Mazumdar, K; Ray, R | 1 |
| Gratsianskiĭ, NA | 1 |
| Laustsen, G; Wimmett, L | 1 |
| Stone, PH | 1 |
| Traut, V | 1 |
| Izumi, T; Kitano, Y; Niwano, S; Sasaki, T | 1 |
| Chiou, SY; Lai, GW; Lin, G; Lin, LY | 1 |
| Araki, E; Fukuda, K; Ishii, N; Kawada, T; Kim-Mitsuyama, S; Kinoshita, H; Matsumura, T; Miyamura, N; Motoshima, H; Nakao, S; Nishikawa, T; Senokuchi, T; Takeya, M; Tsutsumi, A | 1 |
| Asok Kumar, K; Dutta, NK; Mazumdar, K | 1 |
| Ahmed, FR; Khan, MA; Manzoor, S; Nasiri, MI; Salam, FA; Shoaib, MH; Sultan, F; Yousuf, RI | 1 |
| Luteijn, JM; Morris, JK; Oppenheimer, P; Taylor, D; Wald, NJ | 1 |
| Bridgeman, MB; Dalal, KS | 1 |
| Gupta, B; Kerai, S | 1 |
| Alhnan, MA; Dores, F; Forbes, RT; Habashy, R; Isreb, A; Oga, EF; Pereira, BC; Petit, JB | 1 |
| Battegay, M; Cavassini, M; Courlet, P; Decosterd, L; Marzolini, C; Saldanha, SA; Stader, F; Stoeckle, M | 1 |
| Agrali, OB; Kose, KN; Kuru, B; Kuru, L; Noyan, U; Ozener, HO; Yildirim, HS; Yilmaz, S | 1 |
| Al-Lamee, R; Davies, JR; Foley, M; Francis, DP; Ganesananthan, S; Gerber, R; Howard, J; Keeble, TR; Malik, IS; Nijjer, S; Nowbar, AN; O'Kane, P; Petraco, R; Rajkumar, CA; Seligman, H; Sen, S; Sharp, ASP; Shun-Shin, M; Tang, KH | 1 |
| Castagnetti, V; Palazzoli, F; Profeta, C; Santunione, AL; Silingardi, E; Vandelli, D; Verri, P | 1 |
3 review(s) available for amlodipine and cardiovascular agents
| Article | Year |
|---|---|
2004 drug approval highlights: FDA update.
Topics: Administration, Cutaneous; Amlodipine; Anti-Bacterial Agents; Antidepressive Agents; Bronchodilator Agents; Cardiovascular Agents; Drug Approval; Drug Combinations; Duloxetine Hydrochloride; Eplerenone; Estradiol; Excitatory Amino Acid Antagonists; Female; Gastrointestinal Agents; Heptanoic Acids; Humans; Ketolides; Male; Memantine; Osteoporosis, Postmenopausal; Pyrroles; Rifamycins; Rifaximin; Scopolamine Derivatives; Spironolactone; Thiophenes; Tiotropium Bromide; United States | 2005 |
ST-segment analysis in ambulatory ECG (AECG or Holter) monitoring in patients with coronary artery disease: clinical significance and analytic techniques.
Topics: Adrenergic beta-Antagonists; Amlodipine; Cardiovascular Agents; Coronary Artery Disease; Diltiazem; Drug Therapy, Combination; Electrocardiography, Ambulatory; Humans; Hypolipidemic Agents; Prognosis; Randomized Controlled Trials as Topic; Signal Processing, Computer-Assisted; Treatment Outcome | 2005 |
Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future.
Topics: Amlodipine; Animals; Anti-Bacterial Agents; Bacterial Infections; Cardiovascular Agents; Disease Models, Animal; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests | 2010 |
4 trial(s) available for amlodipine and cardiovascular agents
| Article | Year |
|---|---|
A randomized, double-blind comparison of the efficacy and tolerability of once-daily modified-release diltiazem capsules with once-daily amlodipine tablets in patients with stable angina.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiovascular Agents; Diltiazem; Double-Blind Method; Drug Administration Schedule; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Time Factors; Treatment Outcome; Vasodilator Agents | 2001 |
Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Isosorbide; Male; Middle Aged; Myocardial Ischemia | 2002 |
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Physical Exertion; Piperazines; Ranolazine; Survival Analysis | 2004 |
Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Treatment Outcome; Vasodilator Agents | 2021 |
22 other study(ies) available for amlodipine and cardiovascular agents
| Article | Year |
|---|---|
Vasoactive agents modulate matrix metalloproteinase-2 activity by mesangial cells.
Topics: Amlodipine; Analysis of Variance; Angiotensin II; Animals; Calcium Channel Blockers; Cardiovascular Agents; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Gelatinases; Glomerular Mesangium; Indomethacin; Matrix Metalloproteinase 2; Meclofenamic Acid; Metalloendopeptidases; Rats; Vasoconstrictor Agents; Vasodilator Agents | 1995 |
Investigation and optimisation of the use of micellar electrokinetic chromatography for the analysis of six cardiovascular drugs.
Topics: Amlodipine; Atenolol; Cardiovascular Agents; Chromatography; Diltiazem; Electrochemistry; Hydrogen-Ion Concentration; Kinetics; Micelles; Nicardipine; Nifedipine; Osmosis; Sodium Dodecyl Sulfate; Verapamil | 1995 |
New drugs in the cardiovascular arena.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Cardiovascular Diseases; Humans; Quinolines; Sotalol; Vasodilator Agents | 1993 |
Cardioprotective effects of an angiotensin-converting-enzyme inhibitor, imidapril, and Ca2+ channel antagonist, amlodipine, in spontaneously hypertensive rats at established stage of hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Cardiovascular Agents; Collagen; Heart Function Tests; Heart Rate; Hypertension; Imidazoles; Imidazolidines; Male; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1998 |
Long-term preservation of left ventricular function in medically treated patients with coronary artery disease and persistent exercise-induced ischemia.
Topics: Aged; Amlodipine; Anti-Arrhythmia Agents; Atenolol; Cardiovascular Agents; Coronary Disease; Data Interpretation, Statistical; Diastole; Diltiazem; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Follow-Up Studies; Humans; Middle Aged; Nifedipine; Nitrates; Stroke Volume; Systole; Time Factors; Vasodilator Agents; Ventricular Function, Left | 1999 |
Successful management of intractable coronary spasm with a coronary stent.
Topics: Adult; Amlodipine; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vasospasm; Diltiazem; Doxazosin; Drug Resistance; Drug Therapy, Combination; Ergonovine; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Nicorandil; Nitrates; Pyridines; Stents; Ticlopidine; Ventricular Fibrillation | 2000 |
Biochemical changes on the cardioprotective effect of nicorandil and amlodipine during experimental myocardial infarction in rats.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amlodipine; Animals; Cardiovascular Agents; Drug Synergism; Isoproterenol; Lipid Metabolism; Male; Mitochondria, Heart; Myocardial Infarction; Nicorandil; Oxidation-Reduction; Rats; Rats, Wistar; Succinic Acid | 2003 |
Amlodipine: a cardiovascular drug with powerful antimicrobial property.
Topics: Amlodipine; Animals; Anti-Infective Agents; Cardiovascular Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Mice; Microbial Sensitivity Tests | 2003 |
Evaluation of synergism between the aminoglycoside antibiotic streptomycin and the cardiovascular agent amlodipine.
Topics: Aminoglycosides; Amlodipine; Animals; Anti-Bacterial Agents; Cardiovascular Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Mice; Microbial Sensitivity Tests; Salmonella typhimurium; Streptomycin | 2004 |
[Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Exercise Test; Humans; Multicenter Studies as Topic; Piperazines; Placebos; Randomized Controlled Trials as Topic; Ranolazine; Time Factors; Vasodilator Agents | 2004 |
[Patients with coronary disease and normal blood pressure: amlodipine vs. enalapril -- regarding the contribution in DMW 4/2005].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Echocardiography; Enalapril; Humans; Middle Aged; Patient Selection; Randomized Controlled Trials as Topic; Risk Factors; Vasodilator Agents | 2005 |
Two cases of Brugada syndrome associated with spontaneous clinical episodes of coronary vasospasm.
Topics: Acetylcholine; Amlodipine; Calcium Channel Blockers; Cardiovascular Agents; Coronary Vasospasm; Defibrillators, Implantable; Diltiazem; Electric Countershock; Electrocardiography; Fatal Outcome; Heart Function Tests; Humans; Male; Middle Aged; Myocardial Ischemia; Syncope; Ventricular Fibrillation | 2006 |
Kinetics and mechanisms of cholesterol esterase inhibition by cardiovascular drugs in vitro.
Topics: Amlodipine; Cardiovascular Agents; Enzyme Inhibitors; Hydralazine; Kinetics; Nifedipine; Octoxynol; Simvastatin; Sterol Esterase; Taurocholic Acid | 2006 |
Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
Topics: Amlodipine; Animals; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Cardiovascular Agents; Cells, Cultured; Chelating Agents; Chemokine CCL2; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Flavonoids; Humans; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Nifedipine; Phosphorylation; PPAR gamma; Protein Kinase Inhibitors; RNA Interference; RNA, Messenger; Time Factors; Transfection | 2010 |
Simultaneous quantitation of aspirin, amlodipine and simvastatin in a fixed dose combination of encapsulated tablet formulation by HPLC-UV method.
Topics: Amlodipine; Aspirin; Cardiovascular Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Combinations; Limit of Detection; Reproducibility of Results; Simvastatin; Spectrophotometry, Ultraviolet; Tablets; Technology, Pharmaceutical | 2014 |
Cost-benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke.
Topics: Aged; Aged, 80 and over; Amlodipine; Aspirin; Cardiovascular Agents; Case-Control Studies; Cohort Studies; Cost-Benefit Analysis; Humans; Hydrochlorothiazide; Losartan; Markov Chains; Middle Aged; Myocardial Infarction; Polypharmacy; Primary Prevention; Quality-Adjusted Life Years; Simvastatin; Stroke; United Kingdom | 2016 |
Combination cardiovascular drugs.
Topics: Aminobutyrates; Amlodipine; Aspirin; Biphenyl Compounds; Cardiovascular Agents; Cardiovascular Diseases; Drug Combinations; Humans; Nebivolol; Omeprazole; Perindopril; Tetrazoles; Valsartan | 2017 |
Amlodipine toxicity complicated by concurrent medications.
Topics: Amlodipine; Antidepressive Agents; Antihypertensive Agents; Bradycardia; Cardiovascular Agents; Drug Therapy, Combination; Female; Humans; Hypertension; Hypoglycemic Agents; Middle Aged | 2018 |
'Temporary Plasticiser': A novel solution to fabricate 3D printed patient-centred cardiovascular 'Polypill' architectures.
Topics: Amlodipine; Cardiovascular Agents; Cardiovascular Diseases; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Drug Combinations; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Indapamide; Lisinopril; Plasticizers; Polyvinyl Alcohol; Printing, Three-Dimensional; Rosuvastatin Calcium; Tablets; Technology, Pharmaceutical; Temperature; X-Ray Diffraction | 2019 |
Aging does not impact drug--drug interaction magnitudes with antiretrovirals.
Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Atorvastatin; Cardiovascular Agents; Cardiovascular Diseases; Darunavir; Drug Interactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Rosuvastatin Calcium; Treatment Outcome | 2020 |
The gingival crevicular fluid levels of growth factors in patients with amlodipine-induced gingival overgrowth: A pilot study.
Topics: Amlodipine; Cardiovascular Agents; Cardiovascular Diseases; Gingival Crevicular Fluid; Gingival Overgrowth; Humans; Intercellular Signaling Peptides and Proteins; Pilot Projects | 2020 |
Cardiovascular drugs and suicide death: Determination of carvedilol, amlodipine, doxazosin and diltiazem in two fatal cases.
Topics: Amlodipine; Cardiovascular Agents; Carvedilol; Diltiazem; Doxazosin; Humans; Suicide | 2024 |